Pfizer
Long
Updated

Swing trade with 15%+ upside potential

586
Based on RSI and price action, it seems that $25 is a good entry for a swing trade with TP at $29.50+, before next earnings report. The stock has done that move two times from December 2023. The only alarming factor is the sharp fall of OBV, but the risk-reward ratio of the play is very attractive.
Trade active
The stock consolidates between $25 and $27. There was an upward momentum with very good intraday increases in stock price and great volume in those increases, but the stock dipped after each one of them. We failed based on the time horizon of the trade. Although the risk-reward is quite favorable since the stock seems quite steady at these levels, the opportunity cost when observing other tickers in the market is hurting us. Despite that, I will retain my position in PFE for a little longer hoping there will be some good days ahead!

May your portfolio grow and your stress stay low!!

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.